Skip to main content
Tech.euFundingExplorerBeta

Verogen

Exited

next-generation sequencing technologies

Verogen is tracked in the Tech.eu funding database. Based in San Diego, United States; active in Healthtech. Acquired by QIAGEN in 2023. Data as of Nov 2026.

Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—

Funding rounds

0 rounds
No funding rounds recorded.

Exit

Type
acquisition
Date
Jan 2023
Value
€140M
Acquiror
QIAGEN (Netherlands)

Related news

Similar companies

same sector, similar size

Global coverage: FundingData